Greenwich LifeSciences dismisses RBSM, hires MaloneBailey as auditor effective July 19, 2025

Greenwich LifeSciences, Inc.

Audit committee approved dismissing RBSM LLP and engaging MaloneBailey LLP for fiscal 2025 audit.
RBSM's reports for 2024 and 2023 were unqualified; no disagreements on accounting or auditing matters.
Prior material weaknesses in internal control over financial reporting were discussed with RBSM and disclosed in earlier SEC filings.
RBSM provided a letter to the SEC, attached as Exhibit 16.1, agreeing with the Company's disclosures.

item 4.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.